Immune checkpoint inhibitor-associated gastrointestinal and hepatic adverse events and their management

BACKGROUND: Drug-induced colitis is a known complication of therapies that alter the immune balance, damage the intestinal barrier or disturb intestinal microbiota. Immune checkpoint inhibitors (ICI) directed against cancer cells may result in activated T lymphocyte-induced immune-related adverse ev...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Therap Adv Gastroenterol
Autori principali: Shivaji, Uday N., Jeffery, Louisa, Gui, Xianyong, Smith, Samuel C. L., Ahmad, Omer F., Akbar, Ayesha, Ghosh, Subrata, Iacucci, Marietta
Natura: Artigo
Lingua:Inglês
Pubblicazione: SAGE Publications 2019
Soggetti:
Review
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6831976/
https://ncbi.nlm.nih.gov/pubmed/31723355
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756284819884196
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi